... patients with follicular lymphoma John Leonard, M.D., talks to Targeted Oncology about treatment...
https://meyercancer.weill.cornell.edu/news/2023-02-23/weill-cornell-medicine-awa%C3%A2%C2%80%C2%A6?page=34
.... Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell...
https://meyercancer.weill.cornell.edu/news/2023-02-23/weill-cornell-medicine-awa%C3%A2%C2%80%C2%A6?page=19
... of myeloproliferative neoplasms (MPNs). Read more 2017 May 10 Leonard highlights agents, approaches...
https://meyercancer.weill.cornell.edu/news/2023-02-23/weill-cornell-medicine-awa%C3%A2%C2%80%C2%A6?page=18
... Leonard reflects on progress for lymphoma patients John Leonard, M.D., associate director...
https://meyercancer.weill.cornell.edu/news/2023-01-10/scientists-detail-major-me%C3%A2%C2%80%C2%A6?page=47
... patients with follicular lymphoma John Leonard, M.D., talks to Targeted Oncology about treatment...
https://meyercancer.weill.cornell.edu/news/2023-01-10/scientists-detail-major-me%C3%A2%C2%80%C2%A6?page=34
...: Frontline brentuximab monotherapy promising for elderly patients John P. Leonard, M.D., comments...
https://meyercancer.weill.cornell.edu/news/2023-01-10/scientists-detail-major-me%C3%A2%C2%80%C2%A6?page=40
.... Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell...
https://meyercancer.weill.cornell.edu/news/2023-01-10/scientists-detail-major-me%C3%A2%C2%80%C2%A6?page=19
... of myeloproliferative neoplasms (MPNs). Read more 2017 May 10 Leonard highlights agents, approaches...
https://meyercancer.weill.cornell.edu/news/2023-01-10/scientists-detail-major-me%C3%A2%C2%80%C2%A6?page=18
... is reduced in type 2 diabetes.. Nat Cell Biol. 25(4):565-578. Ruan J, Hajjar K, Rafii S, Leonard JP...
https://hartmaninstitute.weill.cornell.edu/publications?page=5&s=author&o=desc
... Biol. 381(2):389-400. Ruan J, Hajjar K, Rafii S, Leonard JP. 2009. Angiogenesis and antiangiogenic...
https://hartmaninstitute.weill.cornell.edu/publications?page=16&s=author&o=asc
